Tadalafil for Sarcoidosis Associated Pulmonary Hypertension (SAPH)

This study is currently recruiting participants.
Verified April 2013 by University of North Carolina, Chapel Hill
Sponsor:
Collaborators:
Eli Lilly and Company
United Therapeutics
Information provided by (Responsible Party):
Hubert M. Ford, MD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01324999
First received: March 24, 2011
Last updated: April 9, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)